Research progress of miR-151-5p in tumor

doi:10.3760/cma.j.issn.1673-422X.2017.06.011

Abstract

Abstract: MicroRNA (miRNA) negatively regulates gene expression at the posttranscriptional level. Studies find that the abnormal expression of miR1515p in various human tumors may play an important role in the development of human tumors, especially in the invasion and metastasis. Further studies of miR1515p contribute to a more indepth understanding of tumor invasion and metastasis, which have potential value in tumor diagnosis, treatment and prognosis.

Key words: Gene expression regulation, Neoplasm invasiveness, Neoplasm metastasis, miR-151-5p

Ke Jianbo, Ling Zhiqiang, Shang Jinbiao. Research progress of miR-151-5p in tumor[J]. Journal of International Oncology, 2017, 44(6): 445-.

References

［1］何祥火, 梁琳慧, 丁洁, 等. 非编码小RNA在肝癌发生中的作用及机制研究进展［J］. 上海交通大学学报: 医学版, 2012, 32(9): 1264-1268. DOI: 10.3969/j.issn.16748115.2012.09.026. ［2］ Bracken CP, Szubert JM, Mercer TR, et al. Global analysis of the mammalian RNA degradome reveals widespread miRNAdependent and miRNAindependent endonucleolytic cleavage［J］. Nucleic Acids Res, 2011, 39(13): 5658-5668. DOI: 10.1093/nar/gkr110. ［3］ Nielsen S, kerstrm T, Rinnov A, et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training［J］. PLoS One, 2014, 9(2): e87308. DOI: 10.1371/journal.pone.0087308. ［4］ Zhang Y, Wang R, Du W, et al. Downregulation of miR1515p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation［J］. PLoS One, 2013, 8(9): e72985. DOI: 10.1371/journal.pone.0072985. ［5］ Paraskevi A, Theodoropoulos G, Papaconstantinou I, et al. Circulating microRNA in inflammatory bowel disease［J］. J Crohns Colitis, 2012, 6(9): 900-904. DOI: 10.1016/j.crohns.2012.02.006. ［6］ Nairismgi ML, Füchtbauer A, Labouriau R, et al. The protooncogene TWIST1 is regulated by microRNAs［J］. PLoS One, 2013, 8(5): e66070. DOI: 10.1371/journal.pone.0066070. ［7］ RoyChaudhuri B, Valdmanis PN, Zhang Y, et al. Regulation of miRNAmediated gene silencing by microRNA precursors［J］. Nat Struct Mol Biol, 2014, 21(9): 825-832. DOI: 10.1038/nsmb.2862. ［8］ Krell J, Frampton AE, Jacob J, et al. The clinicopathologic role of microRNAs miR9 and miR1515p in breast cancer metastasis［J］. Mol Diagn Ther, 2012, 16(3): 167-172. DOI: 10.2165/1163274000000000000000. ［9］ Aure MR, Leivonen SK, Fleischer T, et al. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors［J］. Genome Biol, 2013, 14(11): R126. DOI: 10.1186/gb20131411r126. ［10］ Yu S, Liu Y, Wang J, et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma［J］. J Clin Endocrinol Metab, 2012, 97(6): 2084-2092. DOI: 10.1210/jc.20113059. ［11］ Barnabas N, Xu L, Savera A, et al. Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX31 gene［J］. Prostate, 2011, 71(8): 857-871. DOI: 10.1002/pros.21302. ［12］ Chiyomaru T, Yamamura S, Zaman MS, et al. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA151［J］. PLoS One, 2012, 7(8): e43812. DOI: 10.1371/journal.pone.0043812. ［13］ Presneau N, Eskandarpour M, Shemais T, et al. MicroRNA profiling of peripheral nerve sheath tumours identifies miR29c as a tumour suppressor gene involved in tumour progression［J］. Br J Cancer, 2013, 108(4): 964-972. DOI: 10.1038/bjc.2012.518. ［14］ Ratert N, Meyer HA, Jung M, et al. Reference miRNAs for miRNAome analysis of urothelial carcinomas［J］. PLoS One, 2012, 7(6): e39309. DOI: 10.1371/journal.pone.0039309. ［15］ Niemoeller OM, Niyazi M, Corradini S, et al. MicroRNA expression profiles in human cancer cells after ionizing radiation［J］. Radiat Oncol, 2011, 6: 29. DOI: 10.1186/1748717X629.

[1]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174.
[3]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[4]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying. Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2023, 50(8): 475-483.
[5]	Yang Lirong, Wang Yufeng. Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer [J]. Journal of International Oncology, 2023, 50(4): 220-226.
[6]	Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin. Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma [J]. Journal of International Oncology, 2023, 50(2): 117-121.
[7]	Zhao Jianhao, Duan Yanchao. Research progress in the pathogenesis of extramedullary disease in multiple myeloma [J]. Journal of International Oncology, 2023, 50(1): 55-59.
[8]	Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou. Advances in immunotherapy for recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2022, 49(9): 517-520.
[9]	Peng Chen, Xie Yintong, Zhang Xin, Xie Peng. Research progress of maintenance therapy for cervical cancer [J]. Journal of International Oncology, 2022, 49(7): 430-435.
[10]	Zhang Jing, Huang Shouguo, Xia Ying. Mechanism study of CeRNA regulatory network mediating malignant tumor phenotype [J]. Journal of International Oncology, 2021, 48(9): 544-548.
[11]	Wang Bin, Zhou Jiangyun, Liu Xi. Analysis of the clinical value of different radiotherapy schemes in patients with advanced esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2021, 48(8): 484-488.
[12]	Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells [J]. Journal of International Oncology, 2021, 48(6): 321-327.
[13]	Wang Ziyi, Chen Hongjie, Yang Ninggang, Zhang Jun, Zhang Xiangjun, Yu Xinning, Ma Zhongyi, Dai Enlai. Effects of decorin on proliferation, migration and invasion of bladder cancer cells [J]. Journal of International Oncology, 2021, 48(6): 335-340.
[14]	Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min. Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells [J]. Journal of International Oncology, 2021, 48(4): 206-211.
[15]	Li Bingliang, Yang Ya, Huang Yingli, Si Wen, Li Xingwei, Zhang Yuanmin, Bian Jichao, Chen Yu. Effects of miR-20a-5p targeting KDM6B on the proliferation, migration and invasion of osteosarcoma cells [J]. Journal of International Oncology, 2021, 48(2): 65-73.